Email this article 
Post a Comment The experience of the first Russian latanoprost 0.005% (Trilactan) use in the treatment of primary open-angle glaucoma
- Authors: Tatarintseva A.O.1
-
Affiliations:
- City polyclinic No 17, Specialized Regional Glaucoma Center
- Issue: Vol 11, No 1 (2018)
- Pages: 67-70
- Section: Articles
- URL: https://journals.rcsi.science/ov/article/view/8651
- DOI: https://doi.org/10.17816/OV11167-70
- ID: 8651
Cite item
Full Text
Abstract
Summary. The problem of the reproduced (generic) and original (branded) medications coexistence on the pharmaceutical market is very relevant for Russia. Numerous polls have shown that very few among patients and even doctors clearly understand the differences between original drugs and generics, nor they know how these drugs are produced, and what advantages and weaknesses they have.
Aim. This paper covers the study of Trilactan (0.005% latanoprost, Solopharm, Russia) use in patients with different stages of primary open-angle glaucoma, and includes the analysis of the hypotensive effect and adverse events rate.
Material and methods. The study included 47 patients divided into 3 groups. The first group included 17 treatment-naïve patients (32 eyes). The second group included 14 patients (28 eyes) previously treated with latanoprost 0.005% once a day in the evening at least for a month. The third group consisted of 16 patients (32 eyes) treated with beta-blockers or carbonic anhydrase inhibitors, in whom the target level of intraocular pressure had not been reached. All patients received 1 drop of Trilactan every evening; the observation lasted for 3 months.
Conclusions. The treatment was well tolerated. The intraocular pressure decrease was observed in all cases (p > 0.05). Local and systemic adverse events under Trilactan treatment did not differ from possible side effects typical to the drugs of this pharmacological group in terms of its type and rate.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Alla O. Tatarintseva
City polyclinic No 17, Specialized Regional Glaucoma Center
Author for correspondence.
Email: tatarinceva.alla@mail.ru
Russian Federation, St. Petersburg
References
- Астахов Ю.С., Нечипоренко П.А. Аналоги простагландинов: прошлое, настоящее и будущее // Офтальмологические ведомости. – 2017. – Т. 10. – № 1. – С. 40–52. [Astakhov YuS, Nechiporenko PA. Prostaglandin analogues: past, present, and future. Ophthalmology journal. 2017;10(1):40-52. (In Russ.)]
- Астахов Ю.С., Соколов В.О., Морозова Н.В., и др. Особенности различных методов тонометрии в диагностике и наблюдении глаукомы / VII Российский общенациональный офтальмологический форум. Сборник научных трудов. Москва, 2014 / под ред. В.В. Нероева. – 2014. – Т. 1. – С. 296–299. [Astahov JuS, Sokolov VO, Morozova NV, et al. Osobennosti razlichnyh metodov tonometrii v diagnostike i nabljudenii glaukomy. VII Rossijskij obshhenacional’nyj oftal’mologicheskij forum. Sbornik nauchnyh trudov. Moskva, 2014 / Ed. by V.V. Neroev. 2014;1:296-299. (In Russ.)]
- Егоров Е.А., Астахов Ю.С., Ставицкая Т.В. Общие принципы медикаментозного лечения заболеваний глаз // РМЖ. Клиническая офтальмология. – 2004. – Т. 5. – № 1. – С. 48. [Egorov EA, Astakhov YuS, Stavitskaya TV. General principles of drug treatment of eye diseases. RMJ Clinical Ophthalmology. 2004;5(1):48. (In Russ.)]
- Козлова И.В., Акопян А.И., Рещикова В.С. Эффективность комбинированной терапии у больных первичной открытоугольной глаукомой // Национальный журнал глаукома. – 2011. – Т. 3. – С. 25–29. [Kozlova IV, Akopyan AI, Reshchikova VS. The effectiveness of combination therapy in patients with primary open-angle glaucoma. Natsional’nyi zhurnal glaucoma. 2011;3:25-29. (In Russ.)]
- Национальное руководство по глаукоме для практикующих врачей / Под ред. Е.А. Егорова, Ю.С. Астахова, В.П. Еричева. – 3-е изд. – М.: ГЭОТАР-Медиа, 2015. – 452 c. [Natsional’noe rukovodstvo po glaukome dlya praktikuyuschikh vrachei. 3th ed. Ed. by E.A. Egorov, Yu.S. Astakhov, V.P. Erichev. Moscow: GEOTAR-Media; 2015. 452 p. (In Russ.)]
- Офтальмология: Фармакотерапия без ошибок: Руководство для врачей / Под ред. проф. Ю.С. Астахова, проф. В.П. Николаенко. – Москва: Е-ното, 2016. [Oftal’mologija: Farmakoterapija bez oshibok: Rukovodstvo dlja vrachej. Ed by prof. Ju.S. Astahova, prof. V.P. Nikolaenko. Moscow: E-noto; 2016. (In Russ.)]
- Сamras CB, Alm A, Watson P, Stjernschantz J. Latanoprost, a prostaglandin analog, for glaucoma therapy Efficacyand safety after 1 year of treatment in 198 patients. Latanoprost Study Groups. Ophtalmolodgy. 1996 Nov;103(11):1916-24.
- Heijl A, Leske MC, Bengtsson B, Hyman L, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268-1279.
